GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dishman Carbogen Amics Ltd (NSE:DCAL) » Definitions » EV-to-Revenue

Dishman Carbogen Amics (NSE:DCAL) EV-to-Revenue : 2.22 (As of Jun. 01, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Dishman Carbogen Amics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Dishman Carbogen Amics's enterprise value is ₹60,124 Mil. Dishman Carbogen Amics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₹27,115 Mil. Therefore, Dishman Carbogen Amics's EV-to-Revenue for today is 2.22.

The historical rank and industry rank for Dishman Carbogen Amics's EV-to-Revenue or its related term are showing as below:

NSE:DCAL' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.38   Med: 1.72   Max: 4.2
Current: 2.22

During the past 13 years, the highest EV-to-Revenue of Dishman Carbogen Amics was 4.20. The lowest was 0.38. And the median was 1.72.

NSE:DCAL's EV-to-Revenue is ranked better than
76.73% of 997 companies
in the Biotechnology industry
Industry Median: 7.44 vs NSE:DCAL: 2.22

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-01), Dishman Carbogen Amics's stock price is ₹266.32. Dishman Carbogen Amics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹176.86. Therefore, Dishman Carbogen Amics's PS Ratio for today is 1.51.


Dishman Carbogen Amics EV-to-Revenue Historical Data

The historical data trend for Dishman Carbogen Amics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dishman Carbogen Amics EV-to-Revenue Chart

Dishman Carbogen Amics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.49 2.00 1.64 2.13 1.94

Dishman Carbogen Amics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 1.16 1.87 1.60 1.94

Competitive Comparison of Dishman Carbogen Amics's EV-to-Revenue

For the Biotechnology subindustry, Dishman Carbogen Amics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dishman Carbogen Amics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's EV-to-Revenue falls into.


;
;

Dishman Carbogen Amics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Dishman Carbogen Amics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=60123.742/27115
=2.22

Dishman Carbogen Amics's current Enterprise Value is ₹60,124 Mil.
Dishman Carbogen Amics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹27,115 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dishman Carbogen Amics  (NSE:DCAL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Dishman Carbogen Amics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=266.32/176.855
=1.51

Dishman Carbogen Amics's share price for today is ₹266.32.
Dishman Carbogen Amics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹176.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dishman Carbogen Amics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dishman Carbogen Amics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dishman Carbogen Amics Business Description

Traded in Other Exchanges
Address
Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.

Dishman Carbogen Amics Headlines

No Headlines